Health Archive » December, 2017

Health - December, 2017

241 articles

• Ex-Katten Attorney Convicted Of Aiding Shkreli Fraud
• Ex-Katten Atty's Trial Heads To Jury For The Holidays
• Self-Made IP No Longer Deemed Capital Asset In New Tax Law
• Trump Signs $1.5T Tax Cut Legislation
• 5 Most-Read Legal Industry Articles Of 2017
• Douglas Kills Arbitration Bid In Antitrust Row: 5th Circ.
• Physiotherapy Ex-Owners Denied Appeal In $250M Fraud Suit
• NC Sues Insys Over Scheme To Push Powerful Opioid
• Health Care Exec Can't Pursue Gay Discrimination Suit
• Ex-Katten Atty Cites 'Walls' Of Doubt As Trial Nears End
• Hospitals Urge Judge to Halt $1.6B Cut to Drug Payments
• The Biggest Med Mal Decisions And Verdicts Of 2017
• Congress Passes Temporary Funding, Avoids Shutdown
• Firms Get $7.4M In Fees For $44M Medicare Fraud Settlement
• Second Judge Halts Trump's ACA Birth Control Waiver Rules
• Arbitrators Can't Demand Third-Party Docs, 9th Circ. Says
• USA Gymnastics Paid To Quiet Medalist About Abuse: Suit
• Fla. Hospital Execs Allege Prosecutorial Misconduct
• Spoliation Scrutiny: Disparate Standards For Distinct Mediums
• The Latest FDA Move To Limit Digital Health Software Regs
• Trump's Defense Health Pick Withdraws Over Gun Control
• Atty Relieved In $3M Scam Case After Not Getting Paid
• MVP: Williams & Connolly's Enu Mainigi
• Pa. Nursing Home Settles Patient Death Suit
• Can Gov't Hide Adverse Comments On Proposed Rules?
• Health Care Charity's UBIT Exclusions Denied In Tax Court
• Nursing Home Can't Access Patient Docs On Own, Judge Says
• EEOC's Wellness Rule To Be Thrown Out At Start Of 2019
• Drugmakers Ducked $1.3B In Medicaid Rebates, OIG Says
• Greebel 'Greased Wheels' For Shkreli, Feds Say At Closing
• Banner Health Shakes Contract Claims In Data Breach Row
• FTC Challenges Completed Tie-Up Of Prosthetic Knee Makers
• United Therapeutics Settles Charity-Kickback Claim For $210M
• Gov't Drops Challenge To Abortion For Detained Teen
• My Health To Pay Attys' Fees For 'Stupid Patent' Case
• Senate Dems Ask Agencies About Banned Word Policies
• FTC Tweaks Divestiture Order In Mars' $9.1B VCA Acquisition
• Medical Co. Slams Whistleblower's 'Backward' Appeal Bid
• MVP: Zuckerman Spaeder's D. Brian Hufford
• Exploring Viability Of 'Diagnose And Treat' Method Claims
• House Sends $1.5T Tax Cut Bill To Trump's Desk
• Hearing The Need For More Women's Voices In The Courtroom
• Telehealth In 2017: What Changed And What's Ahead
• GOP Tax Cut Bill Nears Finish Line After Senate Passage
• With Another Flap, Greebel Fraud Trial Heads To Closings
• Health Center Can't Duck Harassment Verdict At 2nd Circ.
• Ill. Health System Blasted In Insurer-Contract Antitrust Row
• FCA Suit Against Sleep-Testing Co. Rouses The Feds
• Meningitis Outbreak MDL, $200M Settlement Fund Near End
• Ill. Appeals Court Affirms Toss Of Brain Damage Case
• Physician Groups Pay $33M To End DOJ Kickback Claims
• MVP: McDermott's Christopher Jedrey
• Dr. Reddy's To Pay $5M To End Feds' Packaging Safety Suit
• My Strangest Day In Court
• House Must Vote Again On Final GOP Tax Bill
• UnitedHealth Hit With RICO Suit Over Pharma Audits
• Humana, PE Firms To Buy And Split Up Kindred In $4.1B Deal
• Health Care Fixes, FISA, CHIP Tacked To Gov't Funding Talks
• Philly Consultant Cops To $1M Lobbying, Kickback Scheme
• Ex-Biotech Exec Denies Tie To Mass. Securities Scheme
• FDA Vows Crackdown On Homeopathic Treatments
• The Biggest Pennsylvania Policy Developments Of 2017
• Pa. Gov. Vetoes Bill To Limit 2nd-Trimester Abortions
• 2nd Circ. Affirms Dismissal Of FCA Suit Against Amgen
• PTAB To Rehear Cook Challenge To Internal-Bleed Device IP
• $10M Pepcid Patent Verdict Nixed As Judge Reverses Herself
• Deals Rumor Mill: Humana, Dole Food, Autodis
• NJ Father, Son Docs Get Prison Over $890K Medicare Scam
• The Biggest​ NJ​​ Policy Developments Of 2017
• Health Care Co. Faces Biometrics Suit Over Finger Scan
• Revisiting The FCA Public Disclosure Bar, Post-Bellevue
• 17 Health Care Tweets That Left A Mark In 2017
• 40 Years Of FCPA
• How 2 Devices And 1 Domain Changed My Practice In 2017
• House, Trump Admin, States Settle ACA Subsidy Battle
• Trump's ACA Birth Control Waivers Blocked By Pa. Judge
• $75M Alliance HealthCare Merger Elicits Appraisal Suit
• Md. Court Affirms Discipline For Doc Who Sold Scrips At Bar
• Del. High Court Affirms $2M Legal Fees To Ex-Optimis CFO
• No Kickback Penalties For Nursing Home Discounts, OIG Says
• PTAB Invalidates Hologic Patent, Rejects Claim Fixes
• Texas High Court Frees Doctors From Defamation Suit
• The Biggest New Jersey Cases Of 2017
• Final GOP Tax Bill Settles On 21% Corporate Rate
• 7th Circ. Affirms Ending Of Policy Rate-Hike Class Action
• Health Hires: Holland & Knight, EBG, Quarles, Ciitizen
• A Chat With Orrick COO Laura Saklad
• Alternative Fees: My Experience At Bartlit Beck
• Doctor Certification Group Sheds Antitrust Case
• House-Senate Negotiators Approve GOP Tax Bill
• Does Indication-Specific Pricing Fit Generics With Carveouts?
• Jurors Should Have An Active Role In Trials
• Rejecting Insanity Defense, Jury Convicts Doctor Of Fraud
• Ill. Appeals Court Revives Hospital Worker's Retaliation Suit
• Gov't Misconduct Claims Blocked From Ex-Katten Atty Trial
• NY High Court Says 'Wrongful Birth' Claims Start At Birth
• DaVita Unit To Pay $64M To Resolve FCA, Kickback Claims
• Appeal Says Fla. Ignored Rules In Hospice License Denial
• Armed Services Chair Backs Temporary Funding Bill
• NJ Banking And Insurance Czar To Join Walsh Pizzi
• Split Texas Panel Sides With AG In Medicaid Docs Fight
• Anti-Vaxxer Can't Sue Hospital Over Firing, 3rd Circ. Says
• Usage Of Uterine Device Down Since Warning, FDA Says
• Harris County Sues Pharma Cos. Over Opioid Epidemic
• Health Provider Must Face Insurer Suit Over Client Death
• J&J Unit Hit With $15M Pelvic Mesh Verdict In NJ
• 40 Years Of FCPA: An Update From The DOJ
• Why Information Governance Is More Important Than Ever
• Electronic System Proposed For Visa Applicants' Med Data
• 6th Circ. Revives $891M Hospital Chain Stock Fraud Suit
• BigLaw Is Behind The Automation Curve
• ND Physician Group Merger Halted For FTC Review
• Boston Lab Again Fails To Dodge Whistleblower's FCA Suit
• Medicaid Providers Not Paying For Long-Term Care, Suit Says
• Optimis Urges Del. Justices To Reverse $2M Ex-CFO Fee
• Ex-Katten Atty Trial Halted Over 'Career-Ending' Claims
• No Coverage For Ex-CEO Of Pot Grower, Insurer Says
• Cancer Treatment Chain Looks To Wipe FCA Claims In Ch. 11
• UPMC Drops Suit Against Atty Over Client Solicitation
• Mass. Launches Review Of Massive Hospital Tie-Up
• Lessons On Losses From 3 Recent FCA Settlements
• 40 Years Of FCPA: Compliance, Past And Future
• Jury To Decide If MD In Fraud Trial Is Insane Or Criminal
• Broward Health Execs Charged For Conspiring To Ax CEO
• State AGs Fight To Block Trump's Birth Control Rules
• Ill. Doctor Gets 14 Mos. For Illegal Drug Distribution
• 11th Circ. Affirms Patient Recruiter Conviction In $2M Fraud
• Calif. Surrogacy Agency Not Covered For Negligence Suit
• GOP Introduces 5 Bills To Delay Affordable Care Act Taxes
• Amgen Whistleblower Was Original Source, 2nd Circ. Told
• Mexican Antitrust Watchdog Fines Latex Glove Makers $13M
• FDA Warning Wire: Chocolate 'Snuff' Sold As Street Drug Sub
• 40 Years Of FCPA: Cross-Border Efforts And Growing Risk
• Ex-Home Health Co. Owner Gets 9 Years For Medicare Fraud
• What To Make Of CVS-Aetna And Other Megadeals
• Judging A Book: Cooke Reviews 'Constance Baker Motley'
• Keeping Your Law Library Relevant In The Age Of Google
• Dueling Experts Tee Up Closing Arguments In MDs' Fraud Trial
• Surgeon Tells Jury Complications Not Limited To J&J Mesh
• Ill. Firm Must Face Privacy Claims Over Deposition Disclosure
• 6 Things You Need To Know About Millennial Jurors
• What Your Colleagues Think Of Litigation Finance
• Why Investors Are Taking The Leap To 3rd-Party Funding
• Has Litigation Finance Shed Its Stigma?
• Ex-Katten Atty's Expert Defends No-Work Consulting Deals
• NLRB Partial Settlements Shift Is Trump Board's 1st Reversal
• UnitedHealth Wants Out Of Medicare FCA Suit
• Retailers Defend Solodyn MDL Claims Against Medicis
• Convicted Pharmacist's Wife Wants To Keep Money, House
• Noted Medical Malpractice Defense Atty Joins Dorf & Nelson
• Deals Rumor Mill: Disney, Ascension Health, GGP
• FDA Issues Final Guidance On Drug Names In Ads
• Justices Won't Hear Appeal Of $8M Health Care Fraud Verdict
• 21st Century To Pay $28M Over Gov't FCA Claims, Data Breach
• NJ Board Revokes Doc's License For Prescription Abuse
• 40 Years Of FCPA: A View From The Monitorship Trenches
• Kirkland Wins As Top Fees Earner In Caesars Ch. 11
• The Law Firms Of The 2017 MVPs
• Law360 MVP Awards Go To Top Attorneys From 78 Firms
• Texas Justices To Hear Challenge To $9.6M MedMal Verdict
• Cancer Center In Ch. 11 To Shell Out $26M In FCA Deal
• Medicaid Scheme Lands NY Businessman 6-Year Sentence
• Pharma Group Sues Calif. Over Drug Pricing Law
• Veteran's Sex-Assault Suit Against VA Staffer Moves Forward
• Katten Atty Says He Never Saw Greebel Break The Law
• No Extra $2.3M FICA Refund For Kansas Education Nonprofit
• 40 Years Of FCPA: The Untold Story Of The Resource Guide
• Taxation With Representation: Shearman, Sullivan, Wachtell
• Is Your Company Ready For Artificial Intelligence?
• Eye Doc Blasts Feds' Loss Calculations Before Sentencing
• 11th Circ. Won't Give LabMD 2nd Bite At Tiversa Fraud Row
• Contractor Sues For $21M Over Bio Warfare Facility Work
• Feds Blast Ex-Pharmacist's Acquittal Bid In Meningitis Row
• NJ Sandy Coverage Row Still Sunk By Lack Of Expert Affidavit
• Ex-Katten Atty Was Corporate Ace At Firm, Jury Hears
• 40 Years Of FCPA: A Journey From Conviction To Dismissal
• Pa. Appeals Court Revives Medical Practice Ownership Fight
• Catholic-Dignity Merger To Forge Nonprofit Health Giant
• Patient Forfeited Forum Choice, Doc Tells 5th Circ.
• Lab CEO Can't Be Named In FCA Retaliation Suit, Court Says
• Deals Rumor Mill: Old Mutual, Fosun, Johnson & Johnson
• 4th Circ. OKs Warrant Used to Convict 'Pill-Mill' Doctor
• BCBS Units Must Produce Additional Docs In Antitrust MDL
• Israel Chemicals Snags Roughly $1B In Sale To PE Firm
• Leveling The Playing Field With The Jury Inference
• 'Tis The Season To Be Mindful Of Workplace Accommodations
• Prosecution In Greebel Case Rests After Hearing Last Witness
• 9th Circ. Affirms Doc's Rx Conviction But Nixes Sentence
• JPML Sends Opioid MDL To Northern Ohio
• Most Senate Dems Demand HHS Pull Birth Control Exemption
• Allergan Says Shire Suit Upends 'Very Fabric' Of Antitrust Law
• Xerox Solely Liable In $1B Medicaid Row, Texas Tells Justices
• Pa. Atty In Contempt Over Privilege For Divorce Records
• Maxim To Repay $14M For Mistakenly Overbilling MassHealth
• Morgan Lewis Says Ex-Client Suing For $30M Waived Conflicts
• Doctor, 3 Nurse Practitioners Charged With Running 'Pill Mill'
• A Closer Look At Disaster Relief Guidance For Health Plans
• Sullivan & Cromwell Advises Optum's $4.9B Clinic Co. Buy
• FCA Attention Turns To Electronic Health Records
• 40 Years Of FCPA: The Siemens Lesson — Tillerson Is Right
• GAO Urges VA To Improve Medical Supply Purchase Program
• 6th Circ. Affirms Toss Of Doctor's Patient Data Suit
• Sen. Presses VA On Alleged Whistleblower Retaliation
• Chubb Unit Tells 2nd Circ. $4.8M Wire Fraud Not Covered
• Ex-Shire Employees Seek To Duck Trade Secrets Complaint
• House OKs Tougher Sentences For Female Genital Mutilation
• Clinic Owner Gets 20 Months For $3.6M BCBS Fraud
• Investor Sues HIG, Bain Capital Over $760M Facility Deal
• Valeant Prices Upsized $1.5B Bond To Refinance Debt
• Fugitive $550M Social Security Fraudster Returned To US
• 40 Years Of FCPA: The Rise In International Enforcement
• GOP Tax Bill Likely To Ax ACA Mandate, Rep. Brady Says
• Is A Shift In DOJ Qui Tam Intervention Policy Coming?
• CVS, Aetna Seek Health Care Industry Shakeup With Megadeal
• Medical Group's Rehiring Ban Is Illegal, 9th Circ. Told
• Deals Rumor Mill: Techem, Alloheim, 21st Century Fox
• High Court Won't Hear Ex-Kan. AG's Suspension Appeal
• Montana AG Hits Purdue With Opioid Suit
• Blasingame Burch Freed From Ex-Client's Pelvic Mesh Suit
• Investors Tell 1st Circ. Sarepta Hid FDA Testing Issues
• Fla. Compounding Pharmacy Can't Escape Tricare FCA Suit
• FBI Pressured Witness With Surprise Visit, Greebel Atty Says
• Feds Can't Skirt $33M Brain Damage Verdict, Family Says
• Morgan Lewis Expands Health Care Practice In Houston
• High Court's Cert Denials Include Same-Sex Benefits Case
• 15 Minutes With The AMA's General Counsel
• 40 Years Of FCPA: Highlights From The 1st Corporate Trial
• Trump's Contraception Rules Suffer From Fatal Legal Flaws
• CVS Inks $69B Takeover Of Aetna
• Congressional Forecast: December
• Senate Passes $1.4 Trillion Tax Cut Legislation
• Mass. AG, Medicaid Billing Co. Reach Deal Over Data Breach
• Texas Justices Won't Hear Houston Doc's Free Speech Row
• Pfizer, Dana-Farber Win Bid For Bristol-Myers Docs In IP Suit
• DC Circ. Won't Rethink Hospital Win In Medicare Pay Battle
• Deals Rumor Mill: Merck, Mednax, Volkswagen
• 40 Years Of FCPA: The Strange Case That Started It All
• Texas Atty Sued For Not Timely Filing Client's Claim
• Fla. Doctor Settles Medicare Billing Fraud Case For $1.95M
• 6th Circ. OKs Ky. Prosecution Of Fla. Pill Mill Workers
• Feds Want Shkreli To Forfeit $7.3M, Wu-Tang Clan Album